Financial PerformanceAfya reported solid results with medical courses tickets increasing 5% YoY, Adj EBITDA margin expanding 290bp YoY and adj. net income up by 29% YoY.
Market PositioningAfya is well positioned in the premium medicine market, with brand recognition being a crucial asset for sustaining long-term medicine ticket prices.
Strategic GrowthAfya's M&A pipeline has increased with new capacity additions, and acquisition multiples may decrease, indicating potential for strategic growth.